INSP Inspire Medical Systems, Inc.

$42.63 +3.72%

Healthcare · Surgical & Medical Instruments & Apparatus

Inspire Medical Systems, Inc. (INSP) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.2 billion. Shares last traded at $42.63, 70.9% below their 52-week high. Over the past year the stock is down 66.5%. INSP trades at a price-to-earnings ratio of 8.45, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 15.9%, above the peer median of -7.6%. Revenue grew 13.6% year over year.

Market Cap

$1.2B

Shares Out

28.8M

EPS (TTM)

$-0.00

P/E Ratio

8.45

P/S Ratio

1.35

P/B Ratio

1.55

Dividend / Share

—

Dividend Yield

—

52-Week High

$146.56

52-Week Low

$38.87

Volume

54,533

Avg Vol (3m)

66,784.698

Performance

+0.50%

+0.28%

-22.04%

-63.10%

YTD

-53.84%

-66.51%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.95

SMA (50)

$47.17

SMA (200)

$73.14

Price vs SMA50

-9.63%

Price vs SMA200

-41.71%

ATR (14)

$2.37

Financials

Revenue

$912M

Net Income

$145M

Gross Margin

85.4%

Operating Margin

5.6%

Net Margin

15.9%

Return on Equity

18.4%

Return on Assets

16.0%

Current Ratio

6.34

Debt / Equity

0.03

Revenue Growth (YoY)

+13.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.39	2026-05-04
FY 2025	$4.89	2026-02-13
Q3 2025	$0.31	2025-11-03
Q2 2025	$-0.02	2025-08-04
Q1 2026	$0.10	2026-05-04
FY 2025	$1.75	2026-02-13

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

INSP vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

8.45 / 28.73 med

-71% discount

P/S vs peers

1.35 / 2.52 med

-47% discount

Net margin vs peers

15.9% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.